Pharma — India Trademark Cases
454 decisions indexed
Page 5 of 16 · 454 total
M/s.Mesmer Pharmaceuticals v.The Registrar of Trade Marks
The Madras High Court set aside the Trade Marks Registry's decision to refuse registration of 'REJUSTAR' in Class 5. The Registrar had cited phonetic similarity to other marks, but the court held that it was premature to determine deceptive similarity based solely on scrutiny under Section 11. Given that the appellant's mark is an invented word and the cited marks were used for different goods or outside India, the matter was remanded back to the Registry for further processing.
Glaxo Group Limited v.Mohd. Nazim And Anr.
The Delhi High Court registered the commercial suit filed by Glaxo Group Limited against Mohd. Nazim And Anr., concerning alleged trademark infringement of 'AUGMENTIN' by the use of 'ZENMENTIN' for similar pharmaceutical products. The court allowed several procedural applications, including exemption from pre-institution mediation and granting permission to submit sealed documents related to sales figures. Crucially, the court directed that notice be issued to the defendants regarding the injunction application (I.A. 5188/2024), setting the stage for a full trial on the infringement claim.
Rexcin Pharmaceuticals P Ltd v.Rekin Pharma P Ltd & Anr.
The Delhi High Court addressed a complex trademark dispute between Rexcin Pharmaceuticals and Rekin Pharma concerning the similar corporate names 'REXCIN' and 'REKIN'. The court noted that while Rexcin holds registrations for 'REXCIN', they are not currently using it commercially, whereas Rekin has registered 'REKIN-SP' in Class 05. To resolve the conflict, the Court proposed a potential settlement where both parties could agree to restrict the use of the disputed term only as part of their corporate name, rather than as a trademark or trade name. Both counsels agreed to consult their clients on this proposal and were directed to consider mediation.
Wings Pharmaceuticals P. Ltd. v.Khatri Healthcare P. Ltd. & Anr.
The Delhi High Court clarified its earlier order in this trademark cancellation petition. The Petitioner, Wings Pharmaceuticals P. Ltd., sought clarification after raising objections regarding territorial jurisdiction. Consequently, the court allowed the application, permitting the Petitioner to withdraw the current case and file a fresh petition before the appropriate Trademark Registry in Mumbai. Crucially, the court emphasized that this withdrawal does not prejudice the parties' rights or express any view on the merits of the original dispute.
Manking Pharma Limited v.Micro Labs Limited
The Madras High Court dismissed the petition filed by Manking Pharma Limited seeking the removal of the trademark 'DOLOBENE' from the register. The court noted that the petitioner failed to appear for the hearing on two consecutive occasions, leading to the dismissal of the original petition for default.
Antex Pharma Pvt Ltd & Anr. v.Elder Projects Ltd & Anr.
The Delhi High Court granted an interim injunction in favor of Antex Pharma Pvt Ltd, restraining Elder Projects Ltd and its representatives from issuing baseless threats of legal action against the plaintiffs concerning the use of the trademark 'ELDER' and 'ELDERVIT'. The court relied heavily on a prior judgment establishing that the registered ownership of the 'ELDER' mark belongs to Elder Pharmaceuticals Limited (EPL), which is currently in liquidation. This ruling protects the plaintiffs from harassment while maintaining that the interim order does not grant them absolute entitlement to use the trademark.
Alkem Laboratories Limited v.Orchid Healthcare (A Division Of)
The Madras High Court allowed Alkem Laboratories Limited's appeal against the Trade Mark Registry's decision to register 'TAXTAM'. The court found that despite the registry listing several differences (such as product type or price), the marks 'TAXIM' and 'TAXTAM' were phonetically and visually deceptively similar. Citing established legal precedent, the High Court set aside the impugned order and directed the rectification of the Trademark Register to protect Alkem's prior rights.
Indchemie Health Specialities Pvt. Ltd. v.M/s.Orchid Chemicals & Pharmaceuticals Limited
The Madras High Court allowed an appeal filed by Indchemie Health Specialities Pvt. Ltd., setting aside a previous rejection by the Trade Marks Registry. The core issue was the similarity between the appellant's registered word mark 'ORKID' and the respondent's applied-for word mark 'ORZID' in Class 5 (pharmaceutical products). The Court found that despite minor spelling differences, the marks were visually similar and capable of causing confusion, thereby directing the rectification of the trademark register.
Sun Pharma Laboratories Ltd. v.The Registrar of Trade Marks
The Madras High Court ruled in favor of Sun Pharma Laboratories, setting aside an order by the Trade Mark Registry that had declared its opposition to a rival mark ('LIBOSE') as abandoned. The core issue was whether the Registry properly served the counter statement to the appellant. The court held that since the Registry failed to provide concrete proof of service—relying only on a website notification—the principle of natural justice was violated, necessitating the remand of the matter.
Dr Reddys Laboratories Limited v.Dr Reddys Pathlabs Private Limited
The Delhi High Court found that Dr Reddys Pathlabs Private Limited was in prima facie contempt of a previous court order by expanding its operations under the 'DR. REDDY'S' mark, even if those new centers were directly owned rather than franchised. The Court ruled that the original undertaking to maintain status quo was intended to prevent any proliferation of business under the contested mark, regardless of ownership structure. Consequently, the Defendant was served with a show cause notice regarding contempt.
Ipca Laboratories Limited v.Amandeep Singh Vohra & Anr.
The Delhi High Court allowed a petition filed by Ipca Laboratories Limited seeking the cancellation of the trademark 'IPKA HEALTHCARE.' This decision was based on a consent decree previously passed by the Bombay High Court, where Respondent No. 1 agreed to remove the impugned mark. The court formally cancelled the registration, reinforcing the principle that prior litigation settlements can drive IP rectification.
Glenmark Pharmaceuticals Ltd. v.Mylan Laboratories Limited
The Madras High Court ruled in favor of Glenmark Pharmaceuticals, allowing its appeal against the Trade Mark Registry's rejection of its opposition. The core issue was the strict adherence to timelines regarding evidence submission. The court held that while deadlines are necessary for discipline, they should not extinguish a party's substantial rights, especially when those rights face imminent threat from registration. Consequently, the opposition has been restored and the matter is directed to be disposed of according to law.
Macleods Pharmaceuticals Ltd. v.Alkem Laboratories Ltd. & Anr.
Macleods Pharmaceuticals filed an application seeking permission from the Delhi High Court to initiate trademark rectification proceedings against Alkem Laboratories. The core issue was challenging the validity of the Defendant's registered mark, ALSITA, in Class 5. The court accepted notice and scheduled the matter for further hearing, allowing the parties time to file their respective responses.
Nectar Biopharma Private Limited v.M/S. Kashmik Formulations Private Limited
In this trademark infringement matter, the Delhi High Court allowed the Plaintiff's application seeking to implead Mr. Nilesh M. Patel, Director of Defendant No. 1. The court found that since Mr. Patel was the proprietor of M/s Nectar Lifecare and his marks were applied for registration, he was a necessary party due to the exclusive supply relationship between Defendant No. 1 and M/s Nectar Lifecare. This decision significantly expands the scope of the litigation by bringing in an individual directly connected to the disputed intellectual property rights.
Pfizer Products Inc. v.Sanjay Rungta T/As M/S Bonsai Pharma
The Gujarat High Court directed the removal of the trademark 'TERCOREX' from the official registry website. The court noted that the trademark was likely to be removed due to non-filing of a renewal request within the prescribed time limit, citing precedents from other high courts. This order effectively cleared the mark from public record, allowing the petitioner liberty to file again should the mark eventually be renewed.
Til Healthcare Private Limited v.M/s.Antop Pharma India Limited
Til Healthcare Private Limited filed a suit against M/s.Antop Pharma India Limited and others, alleging multiple infringements related to the brand 'APETAMIN'. The claims included trademark infringement, passing off, trade dress misuse, and copyright violation concerning its product label. Although the initial prayer sought permanent injunctions and damages, the parties ultimately reached an out-of-court settlement.
Walter Bushnell Pvt Ltd. v.Galaxi Drugs Pvt Ltd.
The Delhi High Court disposed of a trademark cancellation petition filed by Walter Bushnell Pvt Ltd. against Galaxi Drugs Pvt Ltd. The dispute centered on the conflicting marks 'DROTIN' and 'DROTAGAN' in Class 5 (pharmaceuticals). Crucially, the parties reached an out-of-court settlement, leading to Respondent No.1 agreeing to surrender its registration for 'DROTAGAN' and acknowledging the Petitioners' rights in 'DROTIN'. The court accepted this agreement, effectively resolving the dispute.
Corona Remedies Pvt. Ltd. v.Sujatha Manthri trading as Herald Healthcare
The Madras High Court allowed Corona Remedies' petition to rectify the Trade Marks Register, directing the removal of the mark 'B9' (No. 3281514) registered by Sujatha Manthri. The court found that the impugned mark was deceptively similar to the petitioner's established mark 'B29', especially considering both marks were used for pharmaceutical products. Given Corona Remedies' long history of use, significant sales turnover, and reputation, the court ruled in favor of removing the conflicting registration.
M/s.Indian Immunologicals Ltd. v.Ipca Laboratories Pvt. Ltd.
The Madras High Court set aside an earlier rejection order, allowing M/s. Indian Immunologicals Ltd. (the appellant) to register the trade mark 'INIMOX'. The dispute centered on whether 'INIMOX' was deceptively similar to the prior registered mark 'IMOX' held by Ipca Laboratories Pvt. Ltd. The Court found that despite the similarity, there was no likelihood of confusion because the marks were used in distinct channels—one for veterinary injections and the other for human capsules—and mandated that registration be conditional on its use only for animal health products.
The Himalaya Durg Company & Ors v.Himalya International Ltd
In this ongoing trademark infringement suit, the Delhi High Court addressed an application by the defendant seeking permission to file fresh evidence. Despite objections from the plaintiffs that the new defense went beyond pleadings, the court permitted the filing of the affidavit in evidence (DW-1). The court also reminded both parties about the long pendency of the case and directed a day-to-day trial to expedite proceedings.
Himalaya Wellness Company & Ors. v.Prk Productions Llp
Himalaya Wellness Company filed a suit alleging trademark infringement against Prk Productions LLP over the use of 'VIMALAYA' in their film 'Aachar & Co.' The Plaintiffs argued that this usage distorted their established brands like 'HIMALAYA', 'Liv.52', etc., causing consumer confusion. Despite initial denials by the Defendant, the Court found strong evidence supporting the similarity and registered trademarks of the Plaintiff. Consequently, the suit was formally registered, and summons were issued to compel the Defendant to appear and defend the allegations.
Sun Pharma Laboratories Limited v.Hetero Healthcare Limited And Anr
In a complex trademark dispute, Sun Pharma sought permanent injunction against Hetero Healthcare regarding the alleged infringement of its mark 'LETROZ' by 'LETERO'. The court allowed the Defendants to challenge the validity of Sun Pharma's marks through a rectification petition under Section 57. Crucially, the court clarified that while invalidity can be challenged, the primary suit for passing off will proceed independently, leading to framing of multiple issues covering both infringement and validity.
Glaxo Group Limited v.Naresh Kumar Goyal, Trading As Maiden Pharmaceuticals & Anr.
The Delhi High Court addressed a complex interplay between an infringement suit and concurrent rectification petitions concerning pharmaceutical trademarks. The court clarified that while the statute requires rectification to be decided first, the simultaneous filing by the plaintiff preempted the need for a mandatory adjournment. Consequently, the court framed multiple issues covering trademark validity, infringement, passing-off, and defenses like adoption from APIs, setting the case for trial.
M/s.K.P. Namboodiri'S Ayurvedics v.Dr. S. Sajikumar
The Madras High Court disposed of the petition filed by M/s.K.P. Namboodiri'S Ayurvedics against Dr. S. Sajikumar regarding the cancellation of a registered trademark (No. 1914715). The court noted that the contesting parties had entered into a Memorandum of Compromise dated October 31, 2023. Under this settlement, both parties agreed to permit each other's trademarks to coexist in the market and subsequently withdrew all related proceedings.
Lupin Limited v.Tablets (India) Limited
The Madras High Court set aside an earlier rejection order in favor of Lupin Limited, allowing its appeal against the registration of the mark 'CEFTRIL'. The court found that the Registrar's conclusion—that Lupin did not use its prior mark 'CEFF'—was erroneous and contradicted the evidence presented. Furthermore, given the 1st respondent's willingness to seek cancellation, the High Court directed the removal of the disputed trade mark from the register.
Centaur Pharmaceuticals Private Limited v.Sai Mirra Innopharm Private Limited; The Registrar of Trade Marks
The Madras High Court dismissed a petition filed by Centaur Pharmaceuticals seeking the rectification or removal of Trade Mark No. 1409666 from the register. The court found that the trade mark's last valid registration expired long ago, specifically on December 28, 2015. Since the renewal period had lapsed and the petition was based on rectifying an active registration, the court held the case to be infructuous.
Financiere Batteur Sas v.Kalai Arasu Trading As : Spot Light; Registrar of Trade Marks
The Madras High Court dismissed the petition filed by Financiere Batteur Sas seeking the cancellation and removal of Trade Mark No. 2897583, which was registered in Class 5 for the mark 'physiolac' under Kalai Arasu Trading As : Spot Light. The court noted that the subject matter of this petition was identical to another pending case, (T)OP(TM)/481/2023, and consequently closed the current petition without passing any order on costs.
Ind Swift Limited v.Registrar Of Trademarks & Anr.
In this trademark opposition matter, Ind Swift Limited sought an exemption from strict procedural requirements regarding document submission. The Delhi High Court allowed the application, permitting the Appellant to produce original documents later as required by law. The court also noted that the appellant's mark 'AMYCLOX' is opposed by Cedar Properties and Trading LLP, directing necessary intimation to the opposing counsel before listing the matter for further proceedings.
Dr Reddys Laboratories Limited v.Jubilant Generics Limited And Anr
Dr. Reddy's Laboratories filed a suit seeking an injunction against Jubilant Generics for allegedly infringing on its trademark 'RAZO' with the mark 'RAZOEASE'. Following the filing, the Defendant proactively acknowledged an inadvertent mistake and issued assurances to immediately cease all manufacture and sale under the disputed mark. The court accepted these undertakings, leading to the disposal of the injunction application and directing the parties to file consent terms for closure.
M/s.Jupiter Drugs v.Mrs.M.Sarojini
The Madras High Court dismissed M/s. Jupiter Drugs' petition seeking to expunge or limit the trade mark 'ZIPROVIT.' The court noted that the last registration was valid only until December 14, 2017, suggesting the petitioner might no longer be an aggrieved party. Furthermore, due to the absence of a current address for service on the petitioner, the court found it impossible to proceed with the matter.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.